|Page (1) of 1 - 01/19/18||email article||print page|
(January 19, 2018)
MarketResearchFuture.com adds “Alzheimer’s Disease Diagnostic Market -2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022” reports to its database.
The report titled “Alzheimer’s Disease Diagnostic Market -Forecast to 2022? is a direct appreciation by Market Research Future of the market potential of the Alzheimer’s Disease Diagnostic Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market! The global market for this is expected to reach USD 12 billion by the end of the forecasted period growing at a CAGR of 10%.
Market Scenario f Global Alzheimer’s Disease Diagnostic Market:
Alzheimer’s is a type of dementia which causes failure of the functioning of the brain. This disease damages the areas which is responsible for the thinking, problem solving and behavior process. According to the Alzheimer’s association, more than 5 million are living with alzheimer’s and one out of three seniors dies with the Alzheimer’s or any another type of dementia.
One of the most common early symptom of Alzheimer's is difficulty remembering newly learned information. As the Alzheimer's advances through the brain it leads to increasingly severe symptoms which includes bafflement, mood and behavior swings, deepening confusion about events, time and place; unfounded thoughts about family, friends and professional caregivers and more serious memory loss and behavior changes; and difficulty speaking, swallowing and walking.
There are different types of tests to diagnose the symptoms of the alzheimer’s which includes Mini Mental State Exam (MMSE) this tests will help to know whether there are problems with the areas of brain involved in learning, memory, thinking, or planning skills. Other one is brain imaging which includes CT scan, Magnetic Resonance Imaging (MRI); Neuropsychological Testing and genetic tests which provide information regarding the incorrect linking of the genes which causes Alzheimer’s among others.
The development of therapeutic methods and the primary new approvals of drugs that will drive growth during the forecast period which will supplement current market players and offer greater therapeutic options to the patients.
Global Alzheimer’s Disease Diagnostic Market Players:
Some of the key players in this market are: Eli Lilly and Company (UK), TauRx (Republic of Singapore), Alector LLC (US), Accera, Inc. (US), Treventis Corporation (US), Neuro-Bio Ltd (UK), Cognition Therapeutics Inc. (US) and others.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/2149 .
Global Alzheimer’s Disease Diagnostic market:
The Global Alzheimer’s disease diagnostic market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. Factors such rising efforts on research and development by the players to treat Alzheimer’s disease and the introduction of the blockbuster drugs into the market to cure the disease will drive the growth of the market. The global Alzheimer’s disease diagnostic market is expected to grow with CAGR of ~10% during the forecasted period.
Segmentation of Global Alzheimer’s Disease Diagnostic Market:
Global Alzheimer’s disease diagnostic market has been segmented on the basis of type which comprises of early-onset alzheimer's, late-onset alzheimer's, familial Alzheimer’s disease and others. On the basis of diagnostic tests; market is segmented into genetic testing, neurological exam, mini-mental state exam (MMSE), brain imaging and others. On the basis of end users; market is segmented into clinics, hospitals, diagnostic centers and others.
Regional Analysis of Global Alzheimer’s Disease Diagnostic Market:
North America holds the largest market share in global Alzheimer’s disease diagnostic in 2015. The North America Alzheimer’s disease diagnostic market is expected to reach USD 12 Million by the end of the forecast period.
Europe is the second-largest market for Alzheimer’s disease diagnostic. Asia Pacific is expected to be fastest growing region of the Alzheimer’s disease diagnostic market.
Related Keywords:Business,Health & Medicine,Pharmaceuticals & Biotech,U.S,World,
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter